| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10020722 | HBV | ENSG00000271447.6 | protein_coding | MMP28 | No | No | 79148 | B3KV06 C0H5X0 Q9H239 |
| TVIS10043040 | HBV | ENSG00000271447.6 | protein_coding | MMP28 | No | No | 79148 | B3KV06 C0H5X0 Q9H239 |
| TVIS44002415 | HTLV-1 | ENSG00000271447.6 | protein_coding | MMP28 | No | No | 79148 | B3KV06 C0H5X0 Q9H239 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | MMP28 |
|---|---|
| DrugBank ID | DB00786 |
| Drug Name | Marimastat |
| Target ID | BE0003703 |
| UniProt ID | Q9H239 |
| Regulation Type | inhibitor |
| PubMed IDs | 10852638; 10669951 |
| Citations | Heath EI, Grochow LB: Clinical potential of matrix metalloprotease inhibitors in cancer therapy. Drugs. 2000 May;59(5):1043-55.@@Belotti D, Paganoni P, Giavazzi R: MMP inhibitors: experimental and clinical studies. Int J Biol Markers. 1999 Oct-Dec;14(4):232-8. |
| Groups | Investigational |
| Direct Classification | Secondary alcohols |
| SMILES | CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C |
| Pathways | |
| PharmGKB | PA164748329 |
| ChEMBL | CHEMBL279785 |
